Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2025-12-24 @ 4:27 PM
NCT ID:
NCT06220266
Brief Summary:
The goal of this clinical trial is to learn about the effects of phytoestrogen from Pueraria Mirifica in improvement of serum lipid parameters. The primary question it aims to answer are:
• phytoestrogen from Pueraria Mirifica can reduce serum triglyceride, total cholesterol, LDL and increase HDL or not
Participants will receive capsules which composed of dry weight 50 mg of Pueraria Mirifica twice a day for 2 months. Researchers will compare with diet control\&life style modification to see if there is the improvement of serum lipid parameters
Detailed Description:
The secondary question it aims to answer are:
* phytoestrogen from Pueraria Mirifica can reduce menopausal symptom score or not
* phytoestrogen from Pueraria Mirifica can reduce body mass index(BMI) or not
* phytoestrogen from Pueraria Mirifica can reduce waist circumference or not
* phytoestrogen from Pueraria Mirifica can reduce blood pressure or not
* phytoestrogen from Pueraria Mirifica effects to creatinine, BUN, eGFR or not
* phytoestrogen from Pueraria Mirifica effects liver function enzymes or not
Study:
NCT06220266
Study Brief:
Protocol Section:
NCT06220266